OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
62
Results
Show all
Save search
Copy query
Show results for
Unknown
(59)
Genomics
(2)
Transcriptomics
(1)
Organisms
Mus musculus
(3)
Repository
biostudies-arrayexpress
(3)
Instrument Platform
Illumina Genome Analyzer IIx
(2)
Illumina HiSeq 2000
(1)
Publication Date
2014
(3)
Study type
ChIP-seq
(2)
FAIRE-seq
(1)
Release Date
2021
(10)
2022
(8)
2020
(8)
2014
(5)
2024
(4)
2023
(4)
2019
(4)
2015
(4)
2018
(3)
2016
(3)
2013
(3)
2012
(3)
2026
(1)
2025
(1)
2011
(1)
Previous
page
1 / 7
You're on page
1
page
2
page
3
page
4
page
5
page
6
page
7
Next
page
Sort
by:
Relevance
Page size
10
H3K27Ac and H3K4me1 ChIP-seq in Rex1GFPd2 mouse embryonic stem cell line
Chromatin immunoprecipitation using H3K27Ac and H3K4me1 antibodies in Rex1GFPd2 mouse ES cells (parental line; E14Tg2a)
ORGANISM(S):
Mus musculus
2014-06-24
|
E-MTAB-2282
|
biostudies-arrayexpress
Cite
Otx2 ChIP-seq in Rex1GFPd2 mouse embryonic stem cell line
Chromatin immunoprecipitation using Otx2 antibodies in Rex1GFPd2 mouse ES cells (parental line; E14Tg2a)
ORGANISM(S):
Mus musculus
2014-06-24
|
E-MTAB-2281
|
biostudies-arrayexpress
Cite
FAIRE-seq in Rex1GFPd2 mouse embryonic stem cell line
Formaldehyde-assisted isolation of regulatory elements (FAIRE) in Rex1GFPd2 mouse ES cells (parental line; E14Tg2a)
ORGANISM(S):
Mus musculus
2014-06-24
|
E-MTAB-2283
|
biostudies-arrayexpress
Cite
Effect of hypertonic saline on mucociliary clearance and clinical outcomes in chronic bronchitis.
Not available
S-EPMC7418818
|
biostudies-literature
Cite
Inhaled dry powder alginate oligosaccharide in cystic fibrosis: a randomised, double-blind, placebo-controlled, crossover phase 2b study.
Not available
S-EPMC7569163
|
biostudies-literature
Cite
Tezacaftor/Ivacaftor in Subjects with Cystic Fibrosis and F508del/F508del-CFTR or F508del/G551D-CFTR.
Not available
S-EPMC5768901
|
biostudies-literature
Cite
Optimizing nasal potential difference analysis for CFTR modulator development: assessment of ivacaftor in CF subjects with the G551D-CFTR mutation.
Not available
S-EPMC3724869
|
biostudies-literature
Cite
Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2.
Not available
S-EPMC3387216
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998
|
biostudies-literature
Cite
Previous
page
1 / 7
You're on page
1
page
2
page
3
page
4
page
5
page
6
page
7
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets